Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Anupama Pattanaik Article rating: 5.0

Overall volumes in futures & options currently stand at 2,39,77,369 contracts with a turnover of Rs. 15,02,054.73 crore.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Anupama Pattanaik Article rating: 4.7

Overall volumes in futures & options currently stand at 2,39,77,369 contracts with a turnover of Rs. 15,02,054.73 crore.

Index trend and stocks in action September 05, 2019
Index trend and stocks in action September 05, 2019

Index trend and stocks in action September 05, 2019

Karan Dsij Article rating: 3.0

The level of 10,740 is likely to act as a support for the index and a sustainable move below this level would invite further selling and, thereby, there are high chances of retesting its panic low of 10,637 registered on August 23. On the upside, resistance is seen at the level of 10,950. Stocks in news: MCX, Wipro, ICICI Lombard General Insurance Company, Power Grid.

BEML to divest stake from Vignyan Industries
BEML to divest stake from Vignyan Industries

BEML to divest stake from Vignyan Industries

Pritam Bhawar Article rating: 3.9

Bharat Earth Movers Limited (BEML) announced disinvestment of its shareholding of 96.56 per cent in Vignyan Industries Limited (VIL), a subsidiary of BEML Ltd.

Vascon wins Rs 465 crore tender
Vascon wins Rs 465 crore tender

Vascon wins Rs 465 crore tender

Pritam Bhawar Article rating: 3.5

Vascon Engineers Ltd. received an order worth Rs. 465 crore on September 4. The tender was offered by Maharashtra State Police Housing & Welfare Corporation (A Government of Maharashtra undertaking) for construction of staff quarters along with multipurpose hall in Mumbai.

Lupin shares gain on MEK Inhibitor agreement
Lupin shares gain on MEK Inhibitor agreement

Lupin shares gain on MEK Inhibitor agreement

Shohini Nath Article rating: 1.7

Lupin and Boehringer lngelheim have entered into licensing, development and commercialization agreement for Lupin's MEK inhibitor compound (LNP3794).


RSS
First25432544254525462548255025512552Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR